Driving Market Forces for Covid-19 Vaccines Industry: The Case of the Comirnaty Vaccine | ||||
| MSA-Management Sciences Journal | ||||
| Volume 1, Issue 1, August 2022, Page 129-144 PDF (525.9 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/msamsj.2022.180262.1001 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Amr Mohamaden Abdelkader Mohamed 1; Shaimaa N. Abdelaziz 2
| ||||
| 1ESLSCA Business School, ESLSCA University, Cairo, Egypt. Technical Customer Support (TCS), West Pharmaceutical Services Deutschland GmbH & Co KG, Eschweiler, Germany. | ||||
| 2ESLSCA Business School, ESLSCA University, Cairo, Egypt. | ||||
| Abstract | ||||
| Comirnaty, a COVID-19 vaccine developed by BioNTech and Pfizer, has been a significant player in the global fight against the coronavirus pandemic. We studied the Comirnaty vaccine’s demand, supply, demand and supply elasticity and the strategic analysis that consisted of SWOT analysis and PESTEL analysis. Several factors, including the global spread pattern of COVID-19, the vaccine’s effectiveness, and the availability of alternative vaccines, drive the demand for Comirnaty. The supply of Comirnaty is influenced by factors such as manufacturing capacity and the development of new vaccines. The elasticity of demand for Comirnaty is high, with a significant increase in demand at lower prices and a decrease in demand at higher prices. Overall, the market for Comirnaty is complex and dynamic, with demand and supply being influenced by various factors. We expect a dramatic change in the market forces after the announced commercialisation of Comirnaty directly to the end consumer in the USA. | ||||
| Keywords | ||||
| Market analysis; COVID-19 vaccines' market; Market Forces; Demand and Supply | ||||
|
Statistics Article View: 1,264 PDF Download: 301 |
||||
